Publications by authors named "Stephanie Plent"

5Publications

Trends in P2Y12 Inhibitor Use in Patients Referred for Invasive Evaluation of Coronary Artery Disease in Contemporary US Practice.

Am J Cardiol 2016 May 17;117(9):1439-43. Epub 2016 Feb 17.

The Medicines Company, Parsippany, New Jersey.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjcard.2016.02.012DOI Listing
May 2016

Utilization of anticoagulants and outcomes in STEMI patients undergoing PPCI in the US hospitals: Bivalirudin, heparin plus GPI or heparin alone?

Hosp Pract (1995) 2015 18;43(3):164-71. Epub 2015 Jul 18.

The Medicines Company , 8 Sylvan Way, Parsippany, NJ 07054 , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/21548331.2015.1065703DOI Listing
March 2016

Cost implications of intraprocedural thrombotic events during PCI.

Catheter Cardiovasc Interv 2015 Jul 25;86(1):30-9. Epub 2015 Mar 25.

Columbia University Medical Center, New York Presbyterian Hospital and the Cardiovascular Research Foundation, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.25909DOI Listing
July 2015

Economic impact of switching to bivalirudin for a primary percutaneous coronary intervention in a US hospital.

Hosp Pract (1995) 2010 Nov;38(4):138-46

Boston Healthcare Associates, Inc., Boston, MA 02110, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3810/hp.2010.11.351DOI Listing
November 2010